{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T05:21:10Z","timestamp":1788067270115,"version":"build-2784847793"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T00:00:00Z","timestamp":1618272000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81603603,82074425"],"award-info":[{"award-number":["81603603,82074425"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82074425"],"award-info":[{"award-number":["82074425"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81603603"],"award-info":[{"award-number":["81603603"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013077","name":"National Science and Technology Planning Project","doi-asserted-by":"publisher","award":["2016SK2051"],"award-info":[{"award-number":["2016SK2051"]}],"id":[{"id":"10.13039\/501100013077","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008021","name":"Fujian University of Traditional Chinese Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008021","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.biopha.2021.111612","type":"journal-article","created":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T12:55:06Z","timestamp":1619441706000},"page":"111612","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Exploring the effect of Gupi Xiaoji Prescription on hepatitis B virus-related liver cancer through network pharmacology and in vitro experiments"],"prefix":"10.1016","volume":"139","author":[{"given":"Shuxian","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puhua","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenglong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2021.111612_bib1","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.biopha.2021.111612_bib2","first-page":"69","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.biopha.2021.111612_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.soc.2014.09.001","article-title":"Epidemiology of hepatocellular carcinoma","volume":"24","author":"Lafaro","year":"2015","journal-title":"Surg. Oncol. Clin. N. Am."},{"issue":"2","key":"10.1016\/j.biopha.2021.111612_bib4","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.suronc.2016.03.002","article-title":"Hepatocellular carcinoma: from diagnosis to treatment","volume":"25","author":"Grandhi","year":"2016","journal-title":"Surg. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2021.111612_bib5","doi-asserted-by":"crossref","DOI":"10.1177\/1073274817744621","article-title":"Liver resection and surgical strategies for management of primary liver cancer","volume":"25","author":"Orcutt","year":"2018","journal-title":"Cancer Control"},{"issue":"3","key":"10.1016\/j.biopha.2021.111612_bib6","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000504806","article-title":"Expression of c-met in primary and recurrent hepatocellular carcinoma","volume":"98","author":"Asaoka","year":"2020","journal-title":"Oncology"},{"issue":"7","key":"10.1016\/j.biopha.2021.111612_bib7","first-page":"787","article-title":"Liver cancer","volume":"64","author":"Yamashita","year":"2016","journal-title":"Rinsho Byori"},{"issue":"8","key":"10.1016\/j.biopha.2021.111612_bib8","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1111\/liv.14182","article-title":"Family history of liver cancer may modify the association between HBV infection and liver cancer in a Chinese population","volume":"39","author":"Liu","year":"2019","journal-title":"Liver Int."},{"issue":"5","key":"10.1016\/j.biopha.2021.111612_bib9","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2174\/1386207320666170116141818","article-title":"Anticancer properties of traditional Chinese medicine","volume":"20","author":"Yan","year":"2017","journal-title":"Comb. Chem. High Throughput Screen"},{"issue":"9","key":"10.1016\/j.biopha.2021.111612_bib10","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1002\/jcb.25898","article-title":"Balancing between aging and cancer: molecular genetics meets traditional Chinese medicine","volume":"118","author":"Liu","year":"2017","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.biopha.2021.111612_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108812","article-title":"Molecular targets of \u03b2-elemene, a herbal extract used in traditional Chinese medicine, and its potential role in cancer therapy: a review","volume":"114","author":"Zhai","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"01","key":"10.1016\/j.biopha.2021.111612_bib12","first-page":"18","article-title":"Clinical study on YIQI HUAYU JIEDU prescription Combined Javanica oil emulsion through blood vessels involved in treatment of advanced primary liver cancer","volume":"40","author":"Zeng","year":"2013","journal-title":"Liaoning J. Tradit. Chin. Med."},{"issue":"07","key":"10.1016\/j.biopha.2021.111612_bib13","first-page":"1563","article-title":"Effect of YIQI HUAYU JIEDU prescription on Expressions of MVD, HIF1a and VEGF\/KDR from Hepg2 hepatocellular carcinoma nude mice transplantation tumor","volume":"32","author":"Zeng","year":"2014","journal-title":"Chin. Arch. Tradit. Chin. Med."},{"issue":"02","key":"10.1016\/j.biopha.2021.111612_bib14","first-page":"55","article-title":"Effect of YIQI HUAYU JIEDU prescription on the growth of HepG2 nude mice transplantation tumor and the expression of related factors of vascular mimicry","volume":"22","author":"Zeng","year":"2015","journal-title":"Chin. J. Inf. Tradit. Chin. Med."},{"issue":"07","key":"10.1016\/j.biopha.2021.111612_bib15","first-page":"41","article-title":"Effects of YIQI HUAYU JIEDU prescription on MHCC97-H migration ability and expressions of chemokines CXCL12, CXCR4 and CXCR7","volume":"25","author":"Gao","year":"2018","journal-title":"Chin. J. Inf. Tradit. Chin. Med."},{"issue":"10","key":"10.1016\/j.biopha.2021.111612_bib16","first-page":"45","article-title":"Effects of YIQI HUAYU JIEDU prescription on atophagy flow of human hepatocellular carcinoma cell SMCC-7721 based on PI3K\/mTOR pathway","volume":"26","author":"Zhang","year":"2019","journal-title":"Chin. J. Inf. Tradit. Chin. Med."},{"issue":"04","key":"10.1016\/j.biopha.2021.111612_bib17","first-page":"505","article-title":"Intervention Study of YIQI HUAYU JIEDU prescription on the expression of MRP, GST-\u03c0 and Topo II genes in sorafenib acquired resistant human hepatocellular carcinoma QGY7702 cells","volume":"40","author":"Wang","year":"2020","journal-title":"Jilin J. Chin. Med."},{"key":"10.1016\/j.biopha.2021.111612_bib18","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/nbt1007-1110","article-title":"Network pharmacology","volume":"25","author":"Hopkins","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biopha.2021.111612_bib19","doi-asserted-by":"crossref","unstructured":"J. Long, X. Pi, G. Nocca. Polyphyllin I Promoted Melanoma Cells Autophagy and Apoptosis via PI3K\/Akt\/mTOR Signaling Pathway, 2020.","DOI":"10.1155\/2020\/5149417"},{"issue":"6","key":"10.1016\/j.biopha.2021.111612_bib20","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/15376516.2020.1747125","article-title":"Underlying mechanisms of apoptosis in HepG2 cells induced by polyphyllin I through Fas death and mitochondrial pathways","volume":"30","author":"Zeng","year":"2020","journal-title":"Toxicol. Mech. Methods"},{"issue":"1","key":"10.1016\/j.biopha.2021.111612_bib21","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/prot.10524","article-title":"Cytosolic domain of the human mitochondrial fission protein fis1 adopts a TPR fold","volume":"54","author":"Dohm","year":"2004","journal-title":"Proteins"},{"issue":"7641","key":"10.1016\/j.biopha.2021.111612_bib22","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nature21077","article-title":"MFN1 structures reveal nucleotide-triggered dimerization critical for mitochondrial fusion","volume":"542","author":"Cao","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biopha.2021.111612_bib23","doi-asserted-by":"crossref","first-page":"4914","DOI":"10.1038\/s41467-019-12912-0","article-title":"Structural insights of human mitofusin-2 into mitochondrial fusion and CMT2A onset","volume":"10","author":"Li","year":"2019","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.biopha.2021.111612_bib24","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.201907098","article-title":"Structural insights into G domain dimerization and pathogenic mutation of OPA1","volume":"219","author":"Yu","year":"2020","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.biopha.2021.111612_bib25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/978-3-642-38965-8_5","article-title":"Prevention of hepatitis B virus infection and liver cancer","volume":"193","author":"Chang","year":"2014","journal-title":"Recent Results Cancer Res"},{"key":"10.1016\/j.biopha.2021.111612_bib26","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3389\/fendo.2019.00570","article-title":"Dysregulated mitochondrial dynamics and metabolism in obesity, diabetes, and cancer","volume":"10","author":"Dai","year":"2019","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.biopha.2021.111612_bib27","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.918599","article-title":"Mitofusin-2 (Mfn-2) might have anti-cancer effect through interaction with transcriptional factor SP1 and consequent regulation on phosphatidylinositol transfer protein 3 (PITPNM3) expression","volume":"26","author":"Tang","year":"2020","journal-title":"Med Sci. Monit."},{"issue":"1","key":"10.1016\/j.biopha.2021.111612_bib28","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3390\/cells9010121","article-title":"Mitochondrial fusion via OPA1 and MFN1 supports liver tumor cell metabolism and growth","volume":"9","author":"Li","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2021.111612_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/jcp.28334","article-title":"RAS\/MAPK signaling functions in oxidative stress, DNA damage response and cancer progression","author":"Rezatabar","year":"2019","journal-title":"J. Cell Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2021.111612_bib30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12013-013-9762-x","article-title":"Hispidulin induces apoptosis through mitochondrial dysfunction and inhibition of P13k\/Akt signalling pathway in HepG2 cancer cells","volume":"69","author":"Gao","year":"2014","journal-title":"Cell Biochem Biophys."},{"issue":"9","key":"10.1016\/j.biopha.2021.111612_bib31","doi-asserted-by":"crossref","first-page":"7085","DOI":"10.1007\/s13277-015-3420-4","volume":"36","author":"Liang","year":"2015","journal-title":"Tumour Biol."},{"issue":"7","key":"10.1016\/j.biopha.2021.111612_bib32","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1515\/hsz-2016-0130","article-title":"The role of Her2 and other oncogenes of the PI3K\/AKT pathway in mitochondria","volume":"397","author":"Rohlenova","year":"2016","journal-title":"Biol. Chem."},{"issue":"6","key":"10.1016\/j.biopha.2021.111612_bib33","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.5301\/jn.5000089","article-title":"Effect of mitofusin 2 overexpression on the proliferation and apoptosis of high-glucose-induced rat glomerular mesangial cells","volume":"25","author":"Wan-Xin","year":"2012","journal-title":"J. Nephrol."},{"issue":"4","key":"10.1016\/j.biopha.2021.111612_bib34","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.bbagen.2018.01.018","article-title":"Melanoma metabolism contributes to the cellular responses to MAPK\/ERK pathway inhibitors","volume":"1862","author":"Marchetti","year":"2018","journal-title":"Biochim Biophys. Acta Gen. Subj."},{"issue":"5","key":"10.1016\/j.biopha.2021.111612_bib35","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.cmet.2020.04.007","article-title":"Developmental and tumor angiogenesis requires the mitochondria-shaping protein Opa1","volume":"31","author":"Herkenne","year":"2020","journal-title":"Cell Metab."},{"issue":"11","key":"10.1016\/j.biopha.2021.111612_bib36","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.3390\/ijms19113483","article-title":"The mitochondrial genes BAK1, FIS1 and SFN are linked with alterations in mitochondrial membrane potential in Barrett\u2019s esophagus","volume":"19","author":"Phelan","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2021.111612_bib37","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1080\/17460441.2019.1613370","article-title":"The transcriptional factors HIF-1 and HIF-2 and their novel inhibitors in cancer therapy","volume":"14","author":"Albadari","year":"2019","journal-title":"Expert Opin. Drug Disco"},{"issue":"1","key":"10.1016\/j.biopha.2021.111612_bib38","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1631\/jzus.B1400221","article-title":"Hypoxia-inducible factor 1 and breast cancer metastasis","volume":"16","author":"Liu","year":"2015","journal-title":"J. Zhejiang Univ. Sci. B."},{"issue":"2","key":"10.1016\/j.biopha.2021.111612_bib39","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3390\/ijms20020238","article-title":"HIF-1-dependent reprogramming of glucose metabolic pathway of cancer cells and its therapeutic significance","volume":"20","author":"Nagao","year":"2019","journal-title":"Int J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2021.111612_bib40","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.gde.2009.10.009","article-title":"HIF-1: upstream and downstream of cancer metabolism","volume":"20","author":"Semenza","year":"2010","journal-title":"Curr. Opin. Genet Dev."},{"issue":"4","key":"10.1016\/j.biopha.2021.111612_bib41","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.bbrc.2018.04.177","article-title":"ROS mediated EGFR\/MEK\/ERK\/HIF-1\u03b1 Loop Regulates Glucose metabolism in pancreatic cancer","volume":"500","author":"Wang","year":"2018","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.biopha.2021.111612_bib42","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.1038\/s41388-018-0250-z","article-title":"LncRNA PVT1 promotes angiogenesis via activating the STAT3\/VEGFA axis in gastric cancer","volume":"37","author":"Zhao","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2021.111612_bib43","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.neo.2018.03.004","article-title":"The STAT3 target gene TNFRSF1A modulates the NF\u2010kappaB pathway in breast cancer cells","volume":"20","author":"Egusquiaguirre","year":"2018","journal-title":"Neoplasia"},{"key":"10.1016\/j.biopha.2021.111612_bib44","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.3892\/ijmm.2017.3151","article-title":"STAT3 mediates resistance to anoikis and promotes invasiveness of nasopharyngeal cancer cells","volume":"40","author":"Lin","year":"2017","journal-title":"Int J. Mol. Med."},{"issue":"1","key":"10.1016\/j.biopha.2021.111612_bib45","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cmet.2017.11.001","article-title":"JAK\/STAT3-regulated fatty acid \u03b2-oxidation is critical for breast cancer stem cell self-renewal and chemoresistance","volume":"27","author":"Wang","year":"2018","journal-title":"Cell Metab."},{"issue":"9","key":"10.1016\/j.biopha.2021.111612_bib46","doi-asserted-by":"crossref","first-page":"4610","DOI":"10.1002\/cam4.1691","article-title":"Cryptotanshinone suppresses cell proliferation and glucose metabolism via STAT3\/SIRT3 signaling pathway in ovarian cancer cells","volume":"7","author":"Yang","year":"2018","journal-title":"Cancer Med."},{"key":"10.1016\/j.biopha.2021.111612_bib47","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1146\/annurev-med-062613-093128","article-title":"Metformin in cancer treatment and prevention","volume":"66","author":"Morales","year":"2015","journal-title":"Annu Rev. Med."},{"issue":"12","key":"10.1016\/j.biopha.2021.111612_bib48","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1093\/annonc\/mdw410","article-title":"Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis","volume":"27","author":"Coyle","year":"2016","journal-title":"Ann. Oncol."},{"issue":"6","key":"10.1016\/j.biopha.2021.111612_bib49","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s11934-017-0693-8","article-title":"Metformin and prostate cancer: a new role for an old drug","volume":"18","author":"Whitburn","year":"2017","journal-title":"Curr. Urol. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2021.111612_bib50","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1186\/s13046-019-1495-2","article-title":"Metformin in colorectal cancer: molecular mechanism, preclinical and clinical aspects","volume":"38","author":"Kamarudin","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.biopha.2021.111612_bib51","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrendo.2013.256","article-title":"Metformin--mode of action and clinical implications for diabetes and cancer","volume":"10","author":"Pernicova","year":"2014","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.biopha.2021.111612_bib52","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/978-1-4939-7598-3_12","article-title":"Compound C\/dorsomorphin: its use and misuse as an AMPK iInhibitor","volume":"1732","author":"Dasgupta","year":"2018","journal-title":"Methods Mol. Biol."},{"issue":"2","key":"10.1016\/j.biopha.2021.111612_bib53","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.bbrc.2020.01.106","article-title":"Dorsomorphin: a novel inhibitor of Dickkopf-1 in breast cancer","volume":"524","author":"Jaschke","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.biopha.2021.111612_bib54","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.cellsig.2013.11.022","article-title":"Dorsomorphin reverses the mesenchymal phenotype of breast cancer initiating cells by inhibition of bone morphogenetic protein signaling","volume":"26","author":"Garulli","year":"2014","journal-title":"Cell Signal"},{"issue":"5","key":"10.1016\/j.biopha.2021.111612_bib55","doi-asserted-by":"crossref","first-page":"E455","DOI":"10.1002\/ijc.29220","article-title":"Differential cellular responses induced by dorsomorphin and LDN-193189 in chemotherapy-sensitive and chemotherapy-resistant human epithelial ovarian cancer cells","volume":"136","author":"Ali","year":"2015","journal-title":"Int J. Cancer"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221003978?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221003978?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:36:55Z","timestamp":1778693815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221003978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":55,"alternative-id":["S0753332221003978"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111612","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the effect of Gupi Xiaoji Prescription on hepatitis B virus-related liver cancer through network pharmacology and in vitro experiments","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111612","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"111612"}}